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Mammalian Sirtuin 6 (SIRT6) plays an important role in the transcriptional silencing of silent mating-type loci, telomeres, and 
rDNA. However, the roles of porcine SIRT6 in cell proliferation are poorly understood, and a better knowledge of these will help 
improve our understanding of the biological mechanisms of cell growth and development. In this study, a novel variant of porcine 
SIRT6 (SIRT6 V2) identified by reverse transcription-polymerase chain reaction and BLAST analysis showed a 124-bp deletion 
compared to wild-type SIRT6 mRNA (SIRT6 V1). Two recombinant plasmids overexpressing SIRT6 V1 and SIRT6 V2 were pro-
duced and their roles in the proliferation of porcine fetal fibroblasts (PFFs) were compared. Cells transfected with SIRT6 V1 pro-
liferated significantly faster than those transfected with SIRT6 V2 (P<0.01), though both proliferated significantly faster than cells 
expressing an empty vector (P<0.01). These results might be caused by altered proportions of α helices and β sheets in the SIRT6 
V2 structure relative to SIRT6 V1. These results indicate that overexpression of SIRT6 V1/V2 was involved in promoting PFF 
proliferation. Deletion of a 124-bp sequence attenuated the effects of SIRT6 on cell proliferation, possibly as a result of changes in 
the proportions of α helices and β sheets in the protein secondary structure. 
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Yeast silent information regulator 2 (SIR2) possesses 
NAD+-dependent deacetylase and ADP-ribosyltransferase 
activities, and plays essential roles in transcriptional silenc-
ing of silent mating-type loci, telomeres, and rDNA. It also 
represses recombination, chromosomal instability, and age-
ing [1–3].  
SIRT6 is a distant member of the seven SIR2-derived 
homologs. It is expressed predominantly in nuclei and is 
highly correlated with heterochromatic regions. As a mono- 
ADP-ribosyltransferase, SIRT6 uses NAD+ as a cosubstrate 
to transfer the 32P-label from NAD+ to mSIRT6 and histones 
[4–6]. SIRT6 harbors low-level deacetylase activity for 
NAD+-dependent deacetylation of non-histone proteins [7] 
and linking site-specific histones [8–11].  
SIRT6 is present in all eukaryotes including mammals 
[12], and deacetylates histone H3 lysine 9 (H3K9) and his-
tone H3 lysine K56 (H3K56) to maintain dynamic changes 
in their acetylation levels at the telomeres over cell cycles. 
Histone deacetylation modifies the telomeric chromatin by 
preventing chromosomal fusion at the end of telomeres, and 
negatively regulates ageing-correlated gene-expression pro-
grams depending on nuclear factor-B [8,9,13]. SIRT6 de-
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ficiency in mouse embryonic fibroblasts (MEFs) and em-
bryonic cells (ES) leads to hypersensitivity to DNA damage 
and genomic instability with increased chromosome frag-
mentation, detached centromeres, and gaps, indicative of 
chromosomal aberrations [7]. SIRT6 deficiency also attenu-
ates the double-strand-break repair and the base-excise- 
repair pathways in MEFs. SIRT6-deleted cells show in-
creased sensitivity to DNA damage and premature senes-
cence syndrome [7]. Inactivation of SIRT6 led to telomere 
dysfunction and premature senescence in human and mouse 
cells [9].    
Deacetylation of H3K9 and H3K56 by SIRT6 decreases 
global histone acetylation levels in cells, mainly in S phase 
and G2, or during early mitosis [8,9,13]. Mammalian 
SIRT6-deficient MEFs and ES cells grew more slowly than 
wild-type cells in culture, and deletion of SIRT6 led to a 
reduced proliferation rate in several cell types [7,14].  
However, the mechanisms that mediate the effects of 
porcine SIRT6 on cell proliferation remain poorly under-
stood. A comparison between the effects of different vari-
ants on cell proliferation will help to clarify the role of 
SIRT6 in the physiological regulation of cell growth and 
development. In this study, we identified a novel porcine 
SIRT6 variant and constructed plasmids to express the 
wild-type and novel SIRT6 variants, thus allowing the ef-
fects of both variants on porcine fetal fibroblast (PFF) pro-
liferation to be compared.  
1  Materials and methods 
1.1  Reverse transcription-polymerase chain reaction 
(PCR) 
All animal procedures were approved by the Shanghai Care 
and Use Committee, China. Heart, liver, spleen, lung, kid-
ney, stomach, lymph nodes, longissimus dorsi, fat, large 
intestine, and cerebral tissues were harvested from Large 
White pigs. Total RNA was isolated from each tissue using 
Trizol reagent (Invitrogen, USA). cDNA was synthesized 
for reverse transcription-PCR from less than 5 μg of each 
total RNA, according to the manufacturer’s protocol 
(TaKaRa, Japan). cDNA samples (5 L) of the same con-
centration were pooled together to use as a template.  
Porcine SIRT6 cDNA containing a complete or partial 
open reading frame (ORF) was cloned by reverse transcrip-
tion-PCR using the primer S1 (Table 1). cDNAs containing 
complete or partial ORFs were named SIRT6 variant 1 
(SIRT6 V1, wild-type SIRT6 mRNA) and SIRT6 variant 2 
(SIRT6 V2), respectively. The reaction was carried out in a 
volume of 25 L for 5 min at 94°C, 32 cycles of 30 s at 
94°C, 30 s at 60°C, and 40 s at 72°C, ending with 8 min at 
72°C, with 16°C hold. All PCR products were purified us-
ing a MinElute Gel Extraction Kit (Qiagen, USA) and 
cloned into the pMD18-T vector (TaKaRa) for sequencing.   
1.2  Recombinant plasmid production for overexpres-
sion of SIRT6 variants   
Two cDNA fragments of the porcine SIRT6 variants were 
amplified using the purified cDNA fragments as a template. 
The primers used were: forward primer 5′-TTTGAA- 
TTCGCTGGGAATCACCTCCGCCTT-3′ (Xho I, under-
lined), and reverse primer 5′-TATCTCGAGGTGAGGA- 
TGTCGGTGAATTATGCG-3′ (EcoR I, underlined). The 
fragments were cloned into the pMD18-T vector and re-
leased by restriction with Xho I and EcoR I (TaKaRa). The 
purified fragments were inserted into the vector 
pcDNA3.1(−) (Invitrogen) using T4 DNA ligase (TaKaRa) 
at the Xho I/EcoR I site. The constructed plasmids were 
named pcDNA3.1(−)-SIRT6 V1 and V2, and were identi-
fied by restriction profiling and DNA sequencing.   
1.3  Isolation, culture and transfection of PFFs  
The isolation of PFFs was performed as described previ-
ously [15]. Thawed cells were seeded into 25 cm2 flasks for 
expansion. Cells were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM; Gibco, USA) supplemented with 
penicillin (100 IU/mL; Sigma, USA), streptomycin (100 
mg/mL; Sigma), and 10% fetal bovine serum (Invitrogen), 
and maintained at 37°C with 5% CO2 humidified air. PFFs 
were passaged at 95% confluence. The plasmids 
[pcDNA3.1 (−)-SIRT6 V1/V2 and empty vector] were 
transfected using Lipofectamine 2000 (Sigma).  
1.4  Quantitative real-time PCR (qRT-PCR)  
Total RNA extraction and cDNA synthesis were carried out 
as described previously [16]. qRT-PCR was performed us-
ing SYBR Green (TaKaRa) and the ABI Prism 7000 se-
quence detection system (Applied Biosystems, USA). The 
primers S2 (Table 1) used to amplify SIRT6 V1/V2 were 
synthesized according to the shared coding region of both 
variants, with an amplicon of 248 bp. The expression of the 
porcine β-actin gene was evaluated as an internal control. 
The β-actin primer was 146 bp long (Table 1).  
Table 1  The primers for amplification of SIRT6 variants cDNA and 
qRT-PCR     






S1 GGCGGTGAGGATGTCGGTGAA  60 1490/1366 
 GGAGGGACTGTGAGGCAATT    
S2 AAGGGCAAGTGCGGTCT  58.3 248 
 GCCATGTGGGTCTTCGTG    
β-actin TGCGGCATCCACGAAACTAC  58.3 146 
 AGGGCCGTGATCTCCTTCTG    
a) Tm, optimal annealing temperature.  
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The amplification reaction was initiated by pre-incuba- 
tion at 95°C for 1 min, followed by 40 cycles of denatura-
tion at 95°C for 15 s, annealing at 58.3°C for 30 s, and ex-
tension at 72C for 40 s, performed in a 20 L volume con-
taining 10 L SYBR Premix EX Taq GC (2×), 0.4 L of 
each PCR primer, 0.4 L ROX reference dye (50×), and 
0.03 g cDNA. The relative expression levels were calcu-
lated using the 2−CT method, as described previously [17].  
1.5  Western blot analysis  
Antibodies specific for SIRT6 were raised against the fol-
lowing peptide sequence: TMEERGLAPKFDTTFESARPT- 
QTHMALVQLERVGLLRFLVSQNVDGLHVR. This se-
quence represents a region of human SIRT6 with 96% sim-
ilarity with the corresponding region of porcine SIRT6. 
Western blot analysis was performed as described previ-
ously [18]. Briefly, western blots were incubated overnight 
at 4C with primary antibody (1:700; Sigma) to porcine 
SIRT6, anti-glyceraldehyde phosphate 3-dehydrogenase 
(GAPDH) antibody (1:10000; Sigma) in phosphate-buff- 
ered saline (PBS) containing 0.05% Tween 20 with 5% bo-
vine serum albumin. Blots were then incubated with goat 
anti-rabbit horseradish peroxidase-conjugated second anti-
body (1:5000; Sigma) in 5% non-fat milk for 1 h at room 
temperature. The primary antibodies were detected by anti- 
rabbit horseradish peroxidase-conjugated second antibody, 
using anti-GAPDH as an internal control.        
1.6  Cell counts and determination of population dou-
bling times (PDs)  
The harvested cells were seeded into 75 cm2 flasks at 20000 
cells per flask and cultured for 3, 6, 9, 12, and 15 d, respec-
tively. All experiments were repeated three times. The me-
dium containing G418 was changed every 3 d. The cells 
were removed at the end of each culture time and dissolved 
in 2 mL medium containing DMEM and fetal calf serum. 
The cells were counted using a hemocytometer. The aver-
age values were calculated using the formula: AVE = 
(n1+n2+n3)/3, where n1, n2, and n3 were the counted values.    
PDs were calculated according to the formula: PD = 
(logNd–logNi)/log2, where Nd is the average number of 
cells counted, and Ni is the number of cells seeded. A 
growth curve was constructed according to the numbers of 
PDs [19]. PD analysis was used to assess the effects of both 
SIRT6 variants on PFFs in culture. PDs of control cells were 
also calculated and used as a loading control.   
1.7  Statistical analysis    
The significance of differences in cell proliferation and 
qRT-PCR results among cells transfected with empty vector, 
SIRT6 V1 and SIRT6 V2 in five separate experiments were 
identified by one-way analysis of variance with a Benjamini 
and Hochberg false discovery rate (BH-FDR = 0.05) for 
multiple testing correction, followed by Tukey’s post-hoc 
tests using SPSS 10.0 software. The difference was consid-
ered significant at P<0.05, and extremely significant at 
P<0.01. All the data were presented as mean ± SEM. 
1.8  Prediction of SIRT6 variant protein structures  
The deleted sequences in the SIRT6 V2 mRNA relative to 
SIRT6 V1 mRNA were analyzed using a multiple sequence 
alignment program (http://www.ebi.ac.uk/Tools/msa/  
clustalw2/). The coding sequences and corresponding amino 
acid sequences of both SIRT6 variants were predicted using 
a graphical analysis tool (http://www.ncbi.nlm.nih.gov/ 
guide/all/) and the homology domains of both variant pro-
teins were aligned using ClustalW. Version 2.0 of the Phyre 
server (http://www.sbg.bio.ic.ac.uk/servers/phyre/) was used 
to predict the structures of both SIRT6 proteins [20,21].   
2  Results and discussion  
2.1  Identification and analysis of a novel variant of 
porcine SIRT6   
Two porcine SIRT6 variants have previously been isolated, 
one with a 19-bp deletion in exon 1 and a 327-bp deletion in 
exon 8, and the other with a 36-bp deletion in exon 1 and a 
291-bp deletion in exon 8 [22]. In this study, reverse tran-
scription-PCR analysis of SIRT6 transcripts yielded another 
novel SIRT6 variant (Figure 1, not submitted to GenBank) 
compared to wild-type SIRT6 (GenBank accession: 
FJ457624) and expressed sequence tags in GenBank. This 
new variant was determined to have a deletion of 124 bp 




Figure 1  Identification and analysis of a novel variant of porcine SIRT6. Both SIRT6 variant mRNAs are shown relative to the gene sequence of porcine 
SIRT6. The exons are shaded black, except for exon 7 (124 bp), which is shaded white and was deleted in SIRT6 V2 (data not shown, GenBank accession 
number of the cDNA sequence was not obtained). SIRT6, Sirtuin 6; SIRT6 V1, wild-type SIRT6 mRNA; SIRT6 V2, novel variant of porcine SIRT6.   
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SIRT6 (GenBank accession: HQ242712, submitted by our 
laboratory), which represents the complete exon 7 in SIRT6 
V1.  
2.2  Construction of PFFs overexpressing SIRT6 V1 
and SIRT6 V2 
cDNA sequences for SIRT6 V1 and V2 were amplified us-
ing primer S1, and cloned into the PMD18-T vector for se-
quencing. Fragments of 1490 and 1366 bp were subcloned 
into pcDNA3.1 (−) to produce pcDNA3.1(−)-SIRT6 V1 and 
pcDNA3.1(−)-SIRT6 V2. Both recombinant plasmids were 
identified with Xho I/EcoR I (Figure 2) and by DNA se-
quencing (data not shown).   
In order to investigate the differences in cell proliferation 
rates between the cells transfected with SIRT6 V1 and 
SIRT6 V2, we generated PFF lines stably overexpressing 
each variant. No visible cell death or growth retardation was 
observed, and the cells became G418-resistant after 2 weeks 
using G418 at 500 g mL−1. qRT-PCR showed upregulation 
of both SIRT6 variant mRNAs in these cells, to levels at 
least 5-fold higher than the endogenous expression in cells 
transfected with empty control vector. Six overexpressing 
clones were selected for each of SIRT6 V1 and V2 and des-
ignated RM1–RM6 and RN1–RN6, respectively (Figure 
3(a)). Clones RM1 and RN4 showed similar mRNA abun-
dances and were used for further studies. Overexpression of 
both SIRT6 variants was also confirmed by Western blot 
analysis (Figure 3(b)). The same antibody raised against the 
shared region of SIRT6 V1 and SIRT6 V2 was used in the 
two independent experiments. The results showed more 
intense SIRT6 V1 and V2 protein bands in the RM1 and 
RN4 clones than in the control cells. SIRT6 proteins en-
coded by SIRT6 V1 and SIRT6 V2 hybridized to produce 





Figure 2  Identification of plasmids of both SIRT6 variants by restriction 
analysis. Lanes 1, 2: the recombinant plasmids pcDNA3.1(−)-SIRT6 V2 
and pcDNA3.1(−)-SIRT6 V1 were restricted with Xho I/EcoR I. Fragments 
of 5500, 956, and 1080 bp were produced. Lane 3: empty-vector 
pcDNA3.1 (−) was used as a loading control. Lane M: 5000 bp marker.  
 
Figure 3  Construction of PFFs (porcine fetal fibroblasts) overexpressing 
SIRT6 V1 and V2. (a) SIRT6 mRNA expression was examined in six ex-
perimental clones transfected with SIRT6 V1 (RM1–RM6) and six trans-
fected with SIRT6 V2 (RN1–RN6) by qRT-PCR. PFFs transfected with 
empty vector were examined for endogenous expression and served as a 
loading control. (b) Western blot assay was carried out to identify overex-
pression in RM1 cells transfected with SIRT6 V1 and RN4 cells transfected 
with SIRT6 V2. Human SIRT6 antibody was raised against the shared 
region of both SIRT6 variants proteins. GAPDH was used as a loading 
control.  
2.3  Comparison of proliferation promotion by SIRT6 
V1 and SIRT6 V2    
Data were collected at different culture time points. Aver-
age cell counts at each time point were derived using the 
AVE formula for the cells expressing both variants and the 
empty vector, and PDs were calculated. A growth curve was 
constructed based on the various PDs (Figure 4). The PDs 
increased with culture time for all cell lines, and the in-
crease was very slow for the initial 3 d. From the third day 
to the end of the culture period, the rates of increase of RM1 
and RN4 cells were higher than that of the control cells, 
with RM1 cells having the highest increase rate. Control, 
RM1, and RN4 cells increased by 6.65, 8.61, and 7.51 PDs, 
respectively. These results indicate that the cells expressing 
SIRT6 V1 and SIRT6 V2 proliferated faster than the control 
cells, by 1.96 and 0.86 PDs, respectively (P<0.01). Cells 
transfected with SIRT6 V1 proliferated 1.1 PDs faster than 
cells with SIRT6 V2 over the 15 d culture period (P<0.01).  
2.4  Prediction of SIRT6 V1 and V2 protein structures  
The coding sequences of SIRT6 V1 and SIRT6 V2 mRNAs 
with the initiation methionine were predicted to span 1080 
and 651 bp, respectively. The corresponding amino acid 
sequences contained 359 and 216 amino acids (data not  
 Xie X X, et al.   Chin Sci Bull   April (2013) Vol.58 No.10 1173 
 
Figure 4  PDs (population doublings) determination and comparison of 
proliferation promotion between SIRT6 variants. PDs were determined at 
different culture time points, and growth curves were constructed based on 
number of days in culture. Cells transfected with either SIRT6 variant pro-
liferated significantly faster than control cells (P<0.01). The proliferation 
rate of the cells with SIRT6 V1 was significantly higher than that of the 
cells with SIRT6 V2 (P<0.01). Growth curves were constructed for control, 
SIRT6 V1, and SIRT6 V2 cells, respectively.  
shown). The predicted structure of SIRT6 V1 was mainly 
composed of 108 α helices (31.5%) and 89 β sheets (25.9%), 
as shown in Figure 5(a), while the predicted structure of 
SIRT6 V2 was mainly composed of 78 α helices (39.0%) 
and 59 β sheets (29.5%), as shown in Figure 5(b). 
α Helices and β sheets are the two most common types of 
secondary structure, and combine in different ways to create 
different spatial arrangements of polypeptide chains [24,25], 
thus playing essential roles in guiding and promoting the 
early steps described in many folding models [26,27]. Sta-
bilizing mutations of the helix accelerate folding, while de-
stabilizing mutations slow folding [28]. Destabilizing of the 
helix in protein L is the rate-limiting step in folding and 
unfolding, with a more significant influence on the unfold-
ing than on the folding rate. Hydrophobic interactions and 
the residues in the helix are important factors in the rate- 
limiting step in folding [29]. A study of the mechanisms of 
β sheets identified the special spatial formation as the 
rate-limiting step in β-sheet folding [30]. The proportions of 
α helices and β sheets in the predicted structure of SIRT6 
V2 were higher than those in the SIRT6 V1 protein (Figure 
5), as a result of deletion of the 124-bp sequence. This 
might change the interactions of the secondary structures 
and influence their folding and unfolding rates, which in 
turn determine the specific tertiary structure [24,25]. In ad-
dition, all aspects of cell metabolism are catalyzed by en-
zymes, many of which depend on cofactors. The active con-
figuration is produced via the combination of enzyme and 
cofactor, which usually includes an active site that the sub-
strate can interact with [31]. Many enzymes are selective for 
just one substrate, and their activity is inhibited if the active 
site is blocked or the shape of the substrate is changed 
[32,33]. The change in structure of SIRT6 V2 due to the 
deleted 124-bp sequence (Figure 5) might thus alter the in-
teractions between substrate and enzyme, which are in-
volved in the series of reactions associated with cell prolif-
eration. The altered enzyme may provide an active site that 
binds inhibitors more easily than substrates, or may reduce 
the active site thus attenuating the catalytic efficiency of the 
enzyme [34]. These changes might decrease the efficiency 
of SIRT6 variants in terms of the promotion of PFF prolif-
eration. 
In summary, overexpression of both SIRT6 variants 
demonstrated their involvement in the regulation of PFF 
proliferation. The promotion efficiency of SIRT6 V1 over-
expression was significantly higher than that of SIRT6 V2 
(P<0.01). Deletion of a 124-bp sequence (exon 7) in the 
ORF of SIRT6 attenuated its ability to promote PFF prolif-
eration. It is possible that the altered proportions of α heli-




Figure 5  Comparison of predicted SIRT6 V1 and SIRT6 V2 protein structures. The protein structures of SIRT6 V1 and V2 were predicted and compared. 
(a) Predicted structure of SIRT6 V1 was composed mainly of 108 α helices and 89 β sheets, which comprised 31.5% and 25.9% of the polypeptide, respec-
tively. (b) Predicted structure of SIRT6 V2 was composed mainly of 78 α helices and 59 β sheets, comprising 39.0% and 29.5% of the polypeptide, respec-
tively.  
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to SIRT6 V1, may have changed their interactions and al-
tered the folding and unfolding rates, or attenuated the cat-
alytic efficiency of the enzymes associated with cell prolif-
eration.   
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